209 related articles for article (PubMed ID: 32318947)
41. Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: A cost-utility analysis of a hospital's initial experience and reflections on the health care system.
Naffouje SA; O'Donoghue C; Salti GI
J Surg Oncol; 2016 Apr; 113(5):544-7. PubMed ID: 26750613
[TBL] [Abstract][Full Text] [Related]
42. [Intraperitoneal hyperthermic chemotherapy in the management of recurrent peritoneal carcinomatosis. Preliminary results in 5 patients].
Lubrano J; Huet E; Foulatier O; Michel P; Michot F; Ténière P; Scotté M
Gastroenterol Clin Biol; 2006 Nov; 30(11):1297-300. PubMed ID: 17185971
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of repeat cytoreductive surgery and heated intraperitoneal chemotherapy for patients with recurrent peritoneal carcinomatosis from appendiceal and colorectal cancers: a multicentre Canadian study.
Jost E; Mack LA; Sideris L; Dube P; Temple W; Bouchard-Fortier A
Can J Surg; 2020 Feb; 63(1):E71-E79. PubMed ID: 32080999
[TBL] [Abstract][Full Text] [Related]
44. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
[TBL] [Abstract][Full Text] [Related]
45. [Recurrent Peritoneal Metastases after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer].
Königsrainer I; Struller F; Zieker D; Königsrainer A; Beckert S
Zentralbl Chir; 2015 Dec; 140(6):607-9. PubMed ID: 23846542
[TBL] [Abstract][Full Text] [Related]
46. [Cytoreductive surgery and HIPEC for peritoneal malignancies in children].
Seitz G; Fuchs J; Königsrainer I; Warmann SW; Königsrainer A; Beckert S
Zentralbl Chir; 2014 Dec; 139(6):607-12. PubMed ID: 25531634
[TBL] [Abstract][Full Text] [Related]
47. A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology.
Badgwell B; Ikoma N; Murphy MB; Wang X; Estrella J; Roy-Chowdhuri S; Das P; Minsky BD; Lano E; Song S; Mansfield P; Ajani J
Ann Surg Oncol; 2021 Jan; 28(1):258-264. PubMed ID: 32556731
[TBL] [Abstract][Full Text] [Related]
48. ASO Author Reflections: Diaphragmatic Resection Often Is Needed in CRS/HIPEC But Does Not Increase Respiratory Complications.
Segura-Sampedro JJ; Craus-Miguel A; González-Argenté X; Morales-Soriano R
Ann Surg Oncol; 2021 Aug; 28(8):4683-4684. PubMed ID: 33423125
[No Abstract] [Full Text] [Related]
49. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastasis.
Hall B; Padussis J; Foster JM
Surg Clin North Am; 2017 Jun; 97(3):671-682. PubMed ID: 28501254
[TBL] [Abstract][Full Text] [Related]
50. ASO Author Reflections: HIPEC Immunogenic Changes Could be Further Exploited by Immunotherapy to Treat Peritoneal Metastases from Colorectal Cancer.
Alon G; Geva R; Lahat G; Nizri E
Ann Surg Oncol; 2023 May; 30(5):2664-2665. PubMed ID: 36807022
[No Abstract] [Full Text] [Related]
51. ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC.
Khan S; Baumgartner JM
Ann Surg Oncol; 2023 Feb; 30(2):774-775. PubMed ID: 36367628
[No Abstract] [Full Text] [Related]
52. ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning Algorithms.
Greenberg AL; Bartlett DL; Choudry HM; Adam MA
Ann Surg Oncol; 2023 Sep; 30(9):5443-5444. PubMed ID: 37266807
[No Abstract] [Full Text] [Related]
53. Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study.
Maillet M; Glehen O; Lambert J; Goere D; Pocard M; Msika S; Passot G; Elias D; Eveno C; Sabaté JM; Lourenco N; André T; Gornet JM;
Ann Surg Oncol; 2016 Mar; 23(3):863-9. PubMed ID: 26480848
[TBL] [Abstract][Full Text] [Related]
54. ASO Author Reflections: Gastric Cancer with Synchronous Peritoneal Disease-A Clinically Meaningful Survival After CRS and HIPEC in Selected Patients from Italian Peritoneal Surface Malignancies Oncoteam Network.
Marano L; Marrelli D; Roviello F
Ann Surg Oncol; 2021 Dec; 28(13):9071-9072. PubMed ID: 34018086
[No Abstract] [Full Text] [Related]
55. ASO Author Reflections: The Diminishing Role of Adjuvant HIPEC.
Enomoto LM; Shen P
Ann Surg Oncol; 2020 Jan; 27(1):115-116. PubMed ID: 31720936
[No Abstract] [Full Text] [Related]
56. ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.
Hamed AB; Choudry MH
Ann Surg Oncol; 2023 Jul; 30(7):4471-4472. PubMed ID: 37103724
[No Abstract] [Full Text] [Related]
57. Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.
Magge D; Ramalingam L; Shuai Y; Edwards RP; Pingpank JF; Ahrendt SS; Holtzman MP; Zeh HJ; Bartlett DL; Choudry HA
J Surg Oncol; 2017 Sep; 116(3):320-328. PubMed ID: 28628712
[TBL] [Abstract][Full Text] [Related]
58. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
Vaira M; Robella M; Mellano A; Sottile A; De Simone M
Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
[TBL] [Abstract][Full Text] [Related]
59. Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives?
Cortes-Guiral D; Elias D; Cascales-Campos PA; Badía Yébenes A; Guijo Castellano I; León Carbonero AI; Martín Valadés JI; Garcia-Foncillas J; Garcia-Olmo D
World J Gastroenterol; 2017 Jan; 23(3):377-381. PubMed ID: 28210074
[TBL] [Abstract][Full Text] [Related]
60. Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: A retrospective cohort study.
Ye J; Ren Y; Wei Z; Peng J; Chen C; Song W; Tan M; He Y; Yuan Y
Surg Oncol; 2018 Sep; 27(3):456-461. PubMed ID: 30217302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
